(Q50536784)

15 March 2018

title

Stored red blood cell viability is maintained after treatment with a second-generation S-303 pathogen inactivation process. (English)

1 reference

15 March 2018

author name string

Jose A Cancelas

1

1 reference

15 March 2018

Larry J Dumont

2

1 reference

15 March 2018

Neeta Rugg

3

1 reference

15 March 2018

Zbigniew M Szczepiorkowski

4

1 reference

15 March 2018

Louis Herschel

5

1 reference

15 March 2018

Alan Siegel

6

1 reference

15 March 2018

P Gayle Pratt

7

1 reference

15 March 2018

D Nicole Worsham

8

1 reference

15 March 2018

Anne Erickson

9

1 reference

15 March 2018

Meisa Propst

10

1 reference

15 March 2018

Anne North

11

1 reference

15 March 2018

Claire D Sherman

12

1 reference

15 March 2018

Nina A Mufti

13

1 reference

15 March 2018

William F Reed

14

1 reference

15 March 2018

Laurence Corash

15

1 reference

15 March 2018

publication date

13 May 2011

1 reference

15 March 2018

published in

Transfusion

1 reference

15 March 2018

volume

51

1 reference

15 March 2018

issue

11

1 reference

15 March 2018

page(s)

2367-2376

1 reference

15 March 2018

Quantitative estimate of the risks and benefits of possible alternative blood donor deferral strategies for men who have had sex with men.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

The 2003 West Nile virus United States epidemic: the America's Blood Centers experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Leakage of potassium from red blood cells following gamma ray irradiation in the presence of dipyridamole, trolox, human plasma or mannitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Irradiation eradication and pathogen reduction. Ceasing cesium irradiation of blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

White blood cell inactivation after treatment with riboflavin and ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Inactivation of infectious pathogens in labile blood components: meeting the challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Viability of red cells prepared with S-303 pathogen inactivation treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Proposed standardization of methods for determining the 24-hour survival of stored red cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

In vitro and in vivo evaluation of LEUKOSEP HRC-600-C leukoreduction filtration system for red cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

A statistical model for red blood cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

Storage of red blood cells: new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03163.X

10.1111/J.1537-2995.2011.03163.X

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018